Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer

Nat Cancer. 2024 Nov;5(11):1622-1640. doi: 10.1038/s43018-024-00816-y. Epub 2024 Aug 28.

Abstract

How dysregulated liquid-liquid phase separation (LLPS) contributes to the oncogenesis of female triple-negative breast cancer (TNBC) remains unknown. Here we demonstrate that phosphorylated histone deacetylase 6 (phospho-HDAC6) forms LLPS condensates in the nuclei of TNBC cells that are essential for establishing aberrant chromatin architecture. The disordered N-terminal domain and phosphorylated residue of HDAC6 facilitate effective LLPS, whereas nuclear export regions exert a negative dominant effect. Through phase-separation-based screening, we identified Nexturastat A as a specific disruptor of phospho-HDAC6 condensates, which effectively suppresses tumor growth. Mechanistically, importin-β interacts with phospho-HDAC6, promoting its translocation to the nucleus, where 14-3-3θ mediates the condensate formation. Disruption of phospho-HDAC6 LLPS re-established chromatin compartments and topologically associating domain boundaries, leading to disturbed chromatin loops. The phospho-HDAC6-induced aberrant chromatin architecture affects chromatin accessibility, histone acetylation, RNA polymerase II elongation and transcriptional profiles in TNBC. This study demonstrates phospho-HDAC6 LLPS as an emerging mechanism underlying the dysregulation of chromatin architecture in TNBC.

MeSH terms

  • Acetylation
  • Animals
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Chromatin* / metabolism
  • Female
  • Histone Deacetylase 6* / metabolism
  • Humans
  • Hydroxamic Acids / pharmacology
  • Mice
  • Phase Separation
  • Phosphorylation
  • Triple Negative Breast Neoplasms* / metabolism
  • Triple Negative Breast Neoplasms* / pathology

Substances

  • Histone Deacetylase 6
  • Chromatin
  • HDAC6 protein, human
  • Hydroxamic Acids